Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104557604B reveals solvent-free molten salt catalysis for 5-acetylsalicylamide. High yield, eco-friendly process for reliable pharmaceutical intermediate supply.
Advanced rhodium-catalyzed route for MDJ production offering cost reduction and supply chain reliability for fragrance manufacturers globally.
Patent CN110483345A enables green selective oxidation of thioethers. Discover cost-effective pharmaceutical intermediate manufacturing with mild visible light conditions.
Patent CN106349295B reveals mild reduction method. Offers cost reduction in pharma intermediate manufacturing and high-purity aniline derivatives.
Patent CN106349295B reveals mild ruthenium catalysis for nitrobenzene reduction offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN105693475B reveals solid acid catalysis for bisphenol fluorene. Achieve high purity and reduced waste for scalable polymer intermediate manufacturing supply chains.
Patent CN109369678A reveals a cost-effective route for 6-epi-Porantheridine. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN114315528A reveals a mild silver-catalyzed route for 4-diarylmethyl phenols, offering high regioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1198151A details an aqueous biphasic hydrocyanation process improving catalyst life and separation for nitrile production, offering significant supply chain advantages.
Novel visible light catalytic synthesis method offers mild conditions and environmental safety for high-purity pharmaceutical intermediates manufacturing supply chain.
Novel 3-step synthesis of FR20 inhibitor avoids toxic reagents. High atom economy and scalable process for pharmaceutical intermediates.
Patent CN106565439A enables one-step 9-fluorenone synthesis. Achieves 99.7% purity without water washing. Significant cost reduction and supply chain reliability for pharmaceutical intermediates.
High-purity chiral amine intermediate for levopraziquantel. Enzymatic process ensures cost reduction and supply reliability for pharmaceutical manufacturing.
Patent CN1154689A reveals a safer, high-yield process for X-ray contrast agent intermediates using tertiary amines and specific hydrocarbon solvents.
Patent CN113308705B details a green electro-oxidation method for methyl phenylglyoxylate, offering cost reduction in agrochemical manufacturing and high-purity intermediates.
Patent CN118745205A details a plant-derived ursodeoxycholic acid synthesis avoiding animal risks. Offers high purity and scalable supply chain solutions.
Patent CN101597226B reveals a streamlined 2-step synthesis of 6-hydroxy-1-indanone from phenol, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturing.
Patent CN113200843A reveals a Lewis acid catalyzed route for high-purity 5-octanoyl salicylic acid, offering significant cost reduction and supply chain stability.
Novel ether-complexing agent route for Initiator 819 synthesis improves safety and yield while reducing wastewater organic load significantly.
Patent CN114716484A reveals a stable iron complex enabling room temperature oxidative coupling, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.